User profiles for D. R. Schmidt
Daniel R. SchmidtInstructor, Radiation Oncology, Harvard Medical School/Beth Israel Deaconess Verified email at bidmc.harvard.edu Cited by 1551 |
Metabolomics in cancer research and emerging applications in clinical oncology
Metabolomics in cancer research and emerging applications in clinical oncology - Schmidt - …
DISCLOSURES: Daniel Schmidt receives salary support from the National Center for …
DISCLOSURES: Daniel Schmidt receives salary support from the National Center for …
International Union of Pharmacology. LXII. The NR1H and NR1I receptors: constitutive androstane receptor, pregnene X receptor, farnesoid X receptor α, farnesoid X …
…, S Kato, WEN Xie, DJ Mangelsdorf, DR Schmidt… - Pharmacological …, 2006 - ASPET
The nuclear receptors of the NR1H and NR1I subgroups include the constitutive androstane
receptor, pregnane X receptor, farnesoid X receptors, liver X receptors, and vitamin D …
receptor, pregnane X receptor, farnesoid X receptors, liver X receptors, and vitamin D …
Sulfadiazine and pyrimethamine in the postnatal treatment of congenital toxoplasmosis: what are the options?
E Petersen, DR Schmidt - Expert review of anti-infective therapy, 2003 - Taylor & Francis
Pre- and neonatal screening for congenital toxoplasmosis rests upon the assumption that
treatment is beneficial on either acute symptoms or in preventing later reactivation. Postpartum …
treatment is beneficial on either acute symptoms or in preventing later reactivation. Postpartum …
Determinants of tender offer post‐acquisition financial performance
KL Fowler, DR Schmidt - Strategic Management Journal, 1989 - Wiley Online Library
The present study extends previous research efforts and examines relationships between
commonly discussed strategic acquisition factors and long‐term financial performance …
commonly discussed strategic acquisition factors and long‐term financial performance …
Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group
…, QG Wright, M Trocha, DR Schmidt… - Nature chemical …, 2013 - nature.com
In contrast to studies on class I histone deacetylase (HDAC) inhibitors, the elucidation of the
molecular mechanisms and therapeutic potential of class IIa HDACs (HDAC4, HDAC5, …
molecular mechanisms and therapeutic potential of class IIa HDACs (HDAC4, HDAC5, …
The G protein-coupled bile acid receptor, TGR5, stimulates gallbladder filling
…, S Kir, M Umetani, DR Schmidt… - Molecular …, 2011 - academic.oup.com
TGR5 is a G protein-coupled bile acid receptor present in brown adipose tissue and intestine,
where its agonism increases energy expenditure and lowers blood glucose. Thus, it is an …
where its agonism increases energy expenditure and lowers blood glucose. Thus, it is an …
An examination of the anti-adherence activity of cranberry juice on urinary and nonurinary bacterial isolates.
DR Schmidt, AE Sobota - Microbios, 1988 - europepmc.org
In a previous investigation it was demonstrated that cranberry juice cocktail was able to inhibit
adherence in 77 clinical isolates of Escherichia coli obtained from patients with diagnosed …
adherence in 77 clinical isolates of Escherichia coli obtained from patients with diagnosed …
Nuclear bile acid receptor FXR protects against intestinal tumorigenesis
S Modica, S Murzilli, L Salvatore, DR Schmidt… - Cancer research, 2008 - AACR
Bile acids have been considered intestinal tumor promoters, and because they are natural
ligands for the nuclear receptor FXR, we examined the role of FXR in intestinal tumorigenesis. …
ligands for the nuclear receptor FXR, we examined the role of FXR in intestinal tumorigenesis. …
[HTML][HTML] Regulation of bile acid synthesis by fat-soluble vitamins A and D
Bile acids are required for proper absorption of dietary lipids, including fat-soluble vitamins.
Here, we show that the dietary vitamins A and D inhibit bile acid synthesis by repressing …
Here, we show that the dietary vitamins A and D inhibit bile acid synthesis by repressing …
[HTML][HTML] Liver LXRα expression is crucial for whole body cholesterol homeostasis and reverse cholesterol transport in mice
…, J Angdisen, M Fu, DR Schmidt… - The Journal of …, 2012 - Am Soc Clin Investig
Liver X receptors (LXRα and LXRβ) are important regulators of cholesterol and lipid
metabolism, and their activation has been shown to inhibit cardiovascular disease and reduce …
metabolism, and their activation has been shown to inhibit cardiovascular disease and reduce …